Index • Roche Media NewsLink: Roche Media News
|
Roche's obinutuzumab (GA101) significantly reduced the risk of disease progression or death in people with one of the most common forms of blood cancer - Roche Media News May 15, 2013, 6:15 pm
Roche today announced the first results from CLL11, a phase III study of the investigational medicin ... more
FDA approves Tarceva (erlotinib) tablets and cobas EGFR Mutation Test for specific type of lung cancer - Roche Media News May 15, 2013, 12:15 pm
Tarceva is the first personalised medicine approved for the initial treatment of people with EGFR mu ... more
Roche to present important new data reflecting broad cancer pipeline at ASCO - Roche Media News May 15, 2013, 6:15 am
First phase III data on obinutuzumab (GA101) in one of the most commonly diagnosed blood cancers;
... more
FDA approves ACTEMRA for children living with a rare form of arthritis - Roche Media News Apr 30, 2013, 12:15 pm
Roche announced today that the U.S. Food and Drug Administration (FDA) has approved ACTEMRA (tociliz ... more
CHMP recommends conditional EU approval of Roche's Erivedge for advanced basal cell carcinoma, a rare but potentially devastating form of skin cancer - Roche Media News Apr 26, 2013, 12:15 pm
Roche announced today that the European Union #8217;s Committee for Medicinal Products for Human Use ... more
Roche to change Applied Science business structure - Roche Media News Apr 23, 2013, 6:15 am
Roche today announced changes to the management and set-up of its life-science business. The Applied ... more
Roche and Ascletis enter collaboration to advance treatment options for Chinese patients with Hepatitis C - Roche Media News Apr 15, 2013, 6:15 am
Roche and Ascletis announced today that they have entered into a collaboration to develop and commer ... more
Roche Group posts strong sales growth in the first quarter - Roche Media News Apr 11, 2013, 6:15 am
Group sales increase 6% at CER to 11.6 billion Swiss francs; Pharmaceuticals sales rise 7% to 9.2 bi ... more
Roche launches new test for diagnosis and monitoring of thyroid cancer - Roche Media News Apr 4, 2013, 6:15 am
Roche today announced the global launch (except US) of Elecsys Calcitonin, a new laboratory test for ... more
Roche' #146;s breast cancer treatment Perjeta receives recommendation for approval in EU - Roche Media News Dec 14, 2012, 6:23 pm
Roche announced today that the European Union #8217;s Committee for Medicinal Products for Human Use ... more
Roche's personalized medicine Zelboraf receives positive opinion from European authority for the treatment of people with BRAF mutation-positive metastatic melanoma - Roche Media News Dec 16, 2011, 12:21 pm
Roche, today announced that the Committee for Medicinal Products for Human Use (CHMP) has recommende ... more
Roche acquires PVT to strengthen laboratory automation in clinical diagnostics - Roche Media News Mar 19, 2011, 6:45 am
Roche announced today the acquisition of PVT Probenverteiltechnik GmbH based in Waiblingen, Germany ... more
First Phase III study evaluating Roche's ocrelizumab in patients with rheumatoid arthritis meets primary endpoint - Roche Media News Dec 11, 2009, 1:27 am
Roche announced today that STAGE, a Phase III trial evaluating ocrelizumab as a treatment for seropo ... more
Continuous improvements in animal welfare within Roche Research - Roche Media News Sep 24, 2009, 3:25 am
Roche announced the winners of its global 3Rs Award Program - a unique and innovative program that h ... more
For the first time, doctors can predict which hepatitis B patients have the highest chance to achieve treatment success with Pegasys - Roche Media News Feb 16, 2009, 1:19 am
New data presented today showed that, for the first time, doctors can predict which hepatitis B pati ... more
Genentech, Glycart and Roche enter into collaboration agreement for potential cancer therapy - Roche Media News Oct 3, 2008, 2:18 am
Genentech, Inc. (NYSE: DNA), GlycArt, a company wholly-owned by Roche, and Roche (SWX: ROG) have ent ... more
FDA issues complete response letter to Roche for Actemra Biologics License Application - Roche Media News Sep 25, 2008, 4:17 am
Roche today announced that the U.S. Food and Drug Administration (FDA) has issued a complete respons ... more
European approval for Roche`s Pegasys personalises treatment for a subgroup of hepatitis C patients: chance for cure with only four months of treatment - Roche Media News Jun 26, 2008, 2:16 am
Roche announced today that the European Commission has approved a shortened, 16-week course of treat ... more